Literature DB >> 3155514

Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.

R Ramphal, G B Pier.   

Abstract

The mucoid exopolysaccharide of Pseudomonas aeruginosa is thought to confer antiphagocytic properties on mucoid strains of P. aeruginosa, thus allowing them to persist in the respiratory tract. It has also been speculated that the mucoid exopolysaccharide may be the adhesin for mucoid strains, but proof is lacking. We studied the role of the mucoid exopolysaccharide in adherence of mucoid strains in competitive experiments with purified mucoid exopolysaccharide, by measuring the binding of 14C-labeled mucoid exopolysaccharide to injured tracheas and testing whether an antibody against the major epitope of the mucoid exopolysaccharide inhibits adherence of these organisms. Our data show that the purified mucoid exopolysaccharide increased the adherence of four of the mucoid strains tested (by 50 to 300%; P less than 0.001) instead of inhibiting adherence. Radiolabeled mucoid exopolysaccharide bound much better to injured tracheal cells than to normal tracheal cells (P less than 0.001), and antibody against the antigen of strain 2192, the strain from which mucoid exopolysaccharide was prepared, inhibited the adherence of four of five mucoid strains but not the strain lacking this antigen. This antibody also failed to inhibit a nonmucoid revertant from strain 2192, which was previously shown to be inhibited by pili. These data strongly support the thesis that the mucoid exopolysaccharide is the adhesion for mucoid strains of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155514      PMCID: PMC261445          DOI: 10.1128/iai.47.1.1-4.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Enhancement of adhesion of the marine Chlorella vulgaris to glass.

Authors:  T R Tosteson; W A Corpe
Journal:  Can J Microbiol       Date:  1975-07       Impact factor: 2.419

2.  Polyuronic acids produced by Pseudomonas aeruginosa.

Authors:  D M Carlson; L W Matthews
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

3.  Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium.

Authors:  R Ramphal; J C Sadoff; M Pyle; J D Silipigni
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

Review 4.  Microbial exopolysaccharides -- their role in microbial adhesion in aqueous systems.

Authors:  I W Sutherland
Journal:  Crit Rev Microbiol       Date:  1983       Impact factor: 7.624

5.  Influence of mucoidy on antibody coating of Pseudomonas aeruginosa.

Authors:  T J Marrie; G K Harding; A R Ronald; J Dikkema; J Lam; S Hoban; J W Costerton
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

6.  Immunologic investigations of mucoid strains of Pseudomonas aeruginosa: comparison of susceptibility to opsonic antibody in mucoid and nonmucoid strains.

Authors:  R S Baltimore; M Mitchell
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

7.  Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.

Authors:  G B Pier; W J Matthews; D D Eardley
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

Review 8.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

9.  Antiphagocytic Effect of Slime from a Mucoid Strain of Pseudomonas aeruginosa.

Authors:  S Schwarzmann; J R Boring
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

10.  Adherence of mucoid and nonmucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium.

Authors:  R Ramphal; M Pyle
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

  10 in total
  59 in total

Review 1.  Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.

Authors:  H Anwar; J L Strap; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

2.  Adherence of intestinal and extraintestinal Pseudomonas aeruginosa to tissue culture cells.

Authors:  G Bartková; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

Review 3.  Pathogenesis and management of lung disease in cystic fibrosis.

Authors:  M S Zach
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

Review 4.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  An algD-bioluminescent reporter plasmid to monitor alginate production in biofilms.

Authors:  W H Wallace; J T Fleming; D C White; G S Sayler
Journal:  Microb Ecol       Date:  1994-05       Impact factor: 4.552

Review 6.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

7.  Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes.

Authors:  Yu-Fan Tsao; Véronique L Taylor; Smriti Kala; Joseph Bondy-Denomy; Alima N Khan; Diane Bona; Vincent Cattoir; Stephen Lory; Alan R Davidson; Karen L Maxwell
Journal:  J Bacteriol       Date:  2018-10-23       Impact factor: 3.490

Review 8.  Bacterial Extracellular Polysaccharides in Biofilm Formation and Function.

Authors:  Dominique H Limoli; Christopher J Jones; Daniel J Wozniak
Journal:  Microbiol Spectr       Date:  2015-06

9.  Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics.

Authors:  G T Mai; J G McCormack; W K Seow; G B Pier; L A Jackson; Y H Thong
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence.

Authors:  R Baselga; I Albizu; M De La Cruz; E Del Cacho; M Barberan; B Amorena
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.